Optical nanobiosensing of cardiovascular disease​on December 25, 2025 at 1:32 pm

Publication date: 15 February 2026 Source: Clinica Chimica Acta, Volume 582 Author(s): Gulrux Davronova, Nargiza Siradjitdinova, Kadirova Munira, Obidjon Khamraev, Feruza Umarova, Ibragim Askarov, Islamova Odila Abduraimovna, Chay Zoya Sergeyevna, Gulsum Tagiyeva, Isokjon Negmatov, Mamarajab Turobov, Nafisa Qosimova, Mashkhura Safarova  

Analytical verification and comparative assessment of the new Atellica IM high-sensitivity prostate specific antigen assayXavier Filellaon December 22, 2025 at 11:00 am

Clin Chem Lab Med. 2025 Dec 23. doi: 10.1515/cclm-2025-1431. Online ahead of print. ABSTRACT OBJECTIVES: Despite standardization efforts, significant inter-assay variability persists among prostate-specific antigen (PSA) tests, impacting prostate cancer (PCa) diagnosis and monitoring. We aimed to evaluate the analytical and clinical performance of the newly developed Atellica IM high-sensitivity PSA (hsPSA Atellica) assay compared … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520